Ryoo BY - Search Results

1

Sorafenib dose escalation in the treatment of advanced hepatocellular carcinoma.

Kim JE, Ryoo BY, Ryu MH, Chang HM, Suh DJ, Lee HC, Lim YS, Kim KM, Kang YK. Kim JE, et al. Among authors: ryoo by. Oncology. 2012;82(2):119-25. doi: 10.1159/000336082. Epub 2012 Feb 17. Oncology. 2012. PMID: 22354124

2

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Ryoo BY, Kang YK, Im YH, Kim YJ, Kim BS, Kim TY, Jung SH, Park JH, Baek HJ, Kim YC, Shim YM, Kim CM, Zo JI. Ryoo BY, et al. Am J Clin Oncol. 1999 Jun;22(3):253-7. doi: 10.1097/00000421-199906000-00008. Am J Clin Oncol. 1999. PMID: 10362331 Clinical Trial.

3

A phase II trial of DA-125, a novel anthracycline, in advanced non-small-cell lung cancer.

Kang YK, Ryoo BY, Kim TY, Im YH, Kim BS, Park YH, Lee CT. Kang YK, et al. Among authors: ryoo by. Cancer Chemother Pharmacol. 1999;44(6):518-21. doi: 10.1007/s002800051127. Cancer Chemother Pharmacol. 1999. PMID: 10550574 Clinical Trial.

4

Intensified induction followed by high-dose therapy with autologous peripheral blood stem cell support in poor-prognosis aggressive non-Hodgkin's lymphoma: results of a pilot study.

Choi SJ, Ryoo BY, Lee SS, Park Y, Kim BS, Kang YK. Choi SJ, et al. Among authors: ryoo by. Haematologica. 2002 May;87(5):555-7. Haematologica. 2002. PMID: 12010675 Clinical Trial. No abstract available.

5

Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron.

Kang YK, Park YH, Ryoo BY, Bang YJ, Cho KS, Shin DB, Kim HC, Lee KH, Park YS, Lee KS, Heo DS, Kim SY, Cho EK, Lim HY, Kim WK, Lee JA, Kim TY, Lee JC, Yoon HJ, Kim NK. Kang YK, et al. Among authors: ryoo by. J Int Med Res. 2002 May-Jun;30(3):220-9. doi: 10.1177/147323000203000302. J Int Med Res. 2002. PMID: 12166338 Free article. Clinical Trial.

6

Primary malignant lymphoma of the breast: clinicopathological study of nine cases.

Park YH, Kim SH, Choi SJ, Ryoo BY, Kang YK, Lee SS. Park YH, et al. Among authors: ryoo by. Leuk Lymphoma. 2004 Feb;45(2):327-30. doi: 10.1080/10428190310001597892. Leuk Lymphoma. 2004. PMID: 15101719

7

Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.

Park YH, Lee JC, Kim CH, Ryoo BY, Kim HT. Park YH, et al. Among authors: ryoo by. Jpn J Clin Oncol. 2004 May;34(5):245-9. doi: 10.1093/jjco/hyh043. Jpn J Clin Oncol. 2004. PMID: 15231858 Clinical Trial.

8

A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site.

Park YH, Ryoo BY, Choi SJ, Yang SH, Kim HT. Park YH, et al. Among authors: ryoo by. Jpn J Clin Oncol. 2004 Nov;34(11):681-5. doi: 10.1093/jjco/hyh124. Jpn J Clin Oncol. 2004. PMID: 15613558 Review.

9

Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.

Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK; Lymphoma Study Division of the Korean Cancer Study Group. Park YH, et al. Among authors: ryoo by. Ann Hematol. 2006 Apr;85(4):257-62. doi: 10.1007/s00277-005-0060-6. Epub 2006 Jan 17. Ann Hematol. 2006. PMID: 16416337

10

The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.

Kwon JM, Park YH, Kang JH, Kim K, Ko YH, Ryoo BY, Lee SS, Lee SI, Koo HH, Kim WS. Kwon JM, et al. Among authors: ryoo by. Ann Hematol. 2006 Jul;85(7):463-8. doi: 10.1007/s00277-006-0081-9. Epub 2006 Mar 14. Ann Hematol. 2006. PMID: 16534596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters